Equities

Healthy Extracts Inc

HYEX:QBB

Healthy Extracts Inc

Actions
  • Price (USD)3.58
  • Today's Change0.00 / 0.00%
  • Shares traded100.00
  • 1 Year change--
  • Beta2.0002
Data delayed at least 15 minutes, as of Oct 04 2024 17:52 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Healthy Extracts, Inc. is a platform for acquiring, developing, researching, patenting, marketing, and distributing plant-based nutraceuticals. The Company, through BergaMet NA, LLC and Ultimate Brain Nutrients, LLC markets and sells health supplemental products. Its segments include Health Supplements and Corporate. It develops, manufactures, and distributes bergamot-based products (BPF) in tablet and capsule under BergaMet Pro+, BergaMet Mega+O, BergaMet HERHEART, BergaMet Cholesterol Command, BergaMet SPORTSHEART and BergaMet CLINICAL IMMUNE. BPF Bergamet products are distributed in North America that contain Citrus Bergamot SuperFruit. Its BergaMet products are certified organic, vegan friendly, non-GMO and gluten-free. Its UBN develops plant-based health technology neuro-products to improve brain health, including memory, cognition, focus and neuro-energy. Its brain health products are sold under various product labels, including UBN ACTIVATE, UBN RELIEF, and Brain Activate-Gel.

  • Revenue in USD (TTM)2.88m
  • Net income in USD-1.37m
  • Incorporated2014
  • Employees--
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Hoth Therapeutics Inc0.00-7.46m5.72m2.00--0.4756-----1.69-1.690.001.740.00----0.00-67.99-157.07-76.33-177.32------------0.00------31.01------
Coeptis Therapeutics Holdings Inc0.00-16.14m6.73m5.00---------0.5143-0.51430.00-0.01110.00----0.00-284.35-37.29-709.12-38.23------------1.22------43.40------
Bon Natural Life Ltd25.56m2.47m7.03m96.000.67520.06821.870.2752.622.6222.9525.950.525411.402.94266,207.704.9514.046.5920.6827.7530.009.4217.622.3216.880.14380.00-1.2922.32-26.3283.09-6.70--
Integrated BioPharma, Inc.50.32m112.00k7.10m147.0089.390.369216.040.14120.00260.00261.620.63911.954.3210.96342,292.500.433813.150.550519.977.7211.220.22265.871.08--0.0004---0.70060.1357806.25-41.775.96--
Lotus Pharmaceuticals Inc70.79m1.72m7.81m233.000.05240.00082.030.11040.05530.05532.563.580.632137.2717.85303,836.901.5522.841.7126.4035.1041.622.4519.930.442830.800.05160.0028.7131.70-12.2251.1170.48--
CV Sciences Inc15.85m-2.53m8.50m42.00--3.39--0.5366-0.0157-0.01570.0980.01391.691.5525.35377,285.70-26.94-43.42-73.44-77.7546.0651.81-15.95-45.680.2530--0.0114---1.24-19.80133.96-20.87----
Aptorum Group Ltd431.38k-2.82m9.68m3.00--0.3691--22.45-0.9126-0.91260.09544.800.020830.363.88143,793.30-20.92-40.45-19.62-42.362.45-4.04-1,006.30-1,233.681.18--0.1694---66.712.3871.18---78.15--
Bright Green Corp0.00-9.92m9.79m5.00--0.993-----0.0538-0.05380.000.05190.00----0.00-47.48---72.55--------------0.0494------52.54------
Healthy Extracts Inc2.88m-1.37m10.72m----26.79--3.72-0.4725-0.47250.98450.13361.120.665428.03---53.40-53.78-168.81-146.6567.8345.68-47.73-87.530.2059-0.91530.7131--10.41105.93-151.54------
NDT Pharmaceuticals Inc-100.00bn-100.00bn11.84m1.00--0.0661----------1.12-----------164.47---452.47-------6,891.36----0.00---100.00--87.56------
Talphera Inc398.00k-13.70m13.42m15.00--1.05--33.73-0.6353-0.63230.01850.74910.0187----26,533.33-64.37-22.60-78.11-28.55-----3,443.22-714.87----0.00-----21.26-119.16---34.33--
Aytu Biopharma Inc81.00m-15.84m14.39m99.00--0.5043--0.1776-2.86-2.8614.634.640.63642.153.08818,202.00-12.45-27.76-25.70-46.0367.3958.88-19.56-56.450.7916-0.05940.3531---24.5861.737.08------
Cara Therapeutics Inc11.00m-111.08m14.60m55.00--1.26--1.33-2.04-2.040.20170.21150.10631.102.10199,927.30-107.38-35.76-132.61-40.8274.66---1,010.20-162.104.48--0.00---49.929.26-38.65--100.66--
Data as of Oct 04 2024. Currency figures normalised to Healthy Extracts Inc's reporting currency: US Dollar USD
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.